National Pension Service increased its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 9.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 78,391 shares of the company’s stock after buying an additional 6,885 shares during the period. National Pension Service owned about 0.10% of Henry Schein worth $14,297,000 as of its most recent SEC filing.
A number of other hedge funds also recently made changes to their positions in HSIC. Bluestein R H & Co. boosted its stake in shares of Henry Schein by 22.5% in the first quarter. Bluestein R H & Co. now owns 123,224 shares of the company’s stock valued at $20,944,000 after buying an additional 22,608 shares during the last quarter. BlackRock Inc. boosted its stake in shares of Henry Schein by 2,999.6% in the first quarter. BlackRock Inc. now owns 5,595,279 shares of the company’s stock valued at $951,028,000 after buying an additional 5,414,761 shares during the last quarter. Chevy Chase Trust Holdings Inc. boosted its stake in shares of Henry Schein by 1.4% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 269,458 shares of the company’s stock valued at $45,800,000 after buying an additional 3,699 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in Henry Schein by 0.6% in the first quarter. Dimensional Fund Advisors LP now owns 310,134 shares of the company’s stock worth $52,714,000 after buying an additional 1,831 shares in the last quarter. Finally, Swedbank boosted its stake in Henry Schein by 1.6% in the first quarter. Swedbank now owns 1,257,291 shares of the company’s stock worth $213,702,000 after buying an additional 19,885 shares in the last quarter. Hedge funds and other institutional investors own 90.87% of the company’s stock.
Shares of Henry Schein, Inc. (NASDAQ:HSIC) traded up 1.95% during trading on Friday, hitting $170.58. The stock had a trading volume of 628,242 shares. The stock’s 50-day moving average is $181.94 and its 200-day moving average is $175.01. Henry Schein, Inc. has a 12-month low of $146.23 and a 12-month high of $186.99. The stock has a market cap of $13.49 billion, a price-to-earnings ratio of 24.93 and a beta of 1.09.
Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, August 8th. The company reported $1.75 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.73 by $0.02. The business had revenue of $3.06 billion during the quarter, compared to the consensus estimate of $3.05 billion. Henry Schein had a net margin of 4.59% and a return on equity of 19.91%. The firm’s quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.64 EPS. On average, equities research analysts expect that Henry Schein, Inc. will post $7.28 EPS for the current year.
A number of equities research analysts have recently commented on the company. Piper Jaffray Companies began coverage on Henry Schein in a research note on Monday, June 12th. They issued a “neutral” rating and a $200.00 target price on the stock. Jefferies Group LLC reaffirmed a “hold” rating and set a $177.00 price target on shares of Henry Schein in a report on Friday, July 21st. Zacks Investment Research downgraded Henry Schein from a “buy” rating to a “hold” rating in a report on Friday, June 23rd. Credit Suisse Group reissued a “hold” rating and issued a $160.00 target price on shares of Henry Schein in a report on Thursday, July 13th. Finally, Stifel Nicolaus reissued a “hold” rating on shares of Henry Schein in a report on Thursday, July 6th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and seven have issued a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $185.56.
Henry Schein Company Profile
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
What are top analysts saying about Henry Schein Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Henry Schein Inc. and related companies.